Comparative histochemical study of Bowen's disease and actinic keratosis: Preserved normal basal cells in Bowen's disease

European Journal of Histochemistry

Volumn 45, Issue 2, 2001, Pages 177-190

  Ishida, H ^a   Kumakiri, M ^a   Ueda, K ^a   Lao, L M ^a   Yanagihara, M ^b   Asamoto, K ^a   Imamura, Y ^a   Noriki, S ^a   Fukuda, M ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Actinic keratosis; AgNOR; Bowen's disease; DNA instability; Immunohistochemistry; In situ hybridisation

Indexed keywords

ACTIN; CYCLINE; DNA; KERATIN; PROTEIN P53; RETICULIN; SILVER NITRATE;

ARTICLE; BOWEN DISEASE; COMPARATIVE STUDY; ELECTRON MICROSCOPY; ENZYME IMMUNOASSAY; GENETICS; HUMAN; INTERPHASE; KERATOSIS; METABOLISM; METHODOLOGY; PATHOLOGY; SKIN; SKIN TUMOR; STAINING;

ACTINS; BOWEN'S DISEASE; DNA, NEOPLASM; HUMANS; IMMUNOENZYME TECHNIQUES; INTERPHASE; KERATINS; KERATOSIS; MICROSCOPY, ELECTRON; PROLIFERATING CELL NUCLEAR ANTIGEN; RETICULIN; SILVER NITRATE; SKIN; SKIN NEOPLASMS; STAINING AND LABELING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035224202     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: 10.4081/1628     Document Type: Article

References (47)

1. Biesterfeld S., Pennings K., Grussendorf-Conen E.I., and Booking A.: Aneuploidy in actinic keratosis and Bowen's disease-increased risk for invasive squamous cell carcinoma? Br. J. Dermatol. 133, 557-560, 1995.
2. Brash D.E., Rudolph J.A., Simon J.A., Lin A., McKenna G.J., and Baden H.P., Halperin A.J., Ponten J.: A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 88, 10124-10128, 1991.
3. Chuang T.Y., Reizner G.T., Elpern D.J., Stone J.L., and Farmer E.R.: Nonmelanoma skin cancer in Japanese ethnic Hawaiians in Kauai, Hawaii: an incidence report. J. Am. Acad. Dermatol. 33, 422-426, 1995.
4. Cox N.H.: Body site distribution of Bowen's disease. Br. J. Dermatol. 130, 714-716, 1994.
5. Crocker J., and Skilbeck N.: Nucleolar organiser region associated proteins in cutaneous melanotic lesions: a quantitative study. J. Clin. Pathol. 40, 885-889, 1987.
6. De Wit P.E., Kerstens H.M., Poddighe P.J., Van Muijen G.N., and Ruiter D.J.: DNA in situ hybridisation as a diagnostic tool in the discrimination of melanoma and Spitz naevus. J. Pathol. 173, 227-233, 1994.
7. Fukuda M., Miyoshi N., Hattori T., Sugihara H., Hosokawa Y., and Nakanishi K.: Different instability of nuclear DNA at acid hydrolysis in cancer and noncancer cells as revealed by fluorescent staining with acridine orange. Histochemistry 84, 556-560, 1986.
8. Fukuda M., Noriki S., Imamura Y., Miyoshi N., Kimura S., Koizumi K., Suzuki K., Sakurai H., and Sakaguchi R.: Differential immunohistochemical staining of cancer cells with anti-single-stranded DNA antiserum in ordinary pathological paraffin section after DNA-denaturation by acid hydrolysis. Eur. J. Histochem. 37, 309-319, 1993.
9. Fuller L.C., Allen M.H., Montesu M., Barker J.N., and Macdonald D.M.: Expression of E-cadherin in human epidermal non-melanoma cutaneous tumours. Br. J. Dermatol. 134, 28-32, 1996.
10. Geary W.A., and Cooper P.H.: Proliferating cell nuclear antigen (PCNA) in common epidermal lesions. An immunohistochemical study of proliferating cell populations. J. Cutan. Pathol. 19, 458-468, 1992.
11. Glogau R.G.: The risk of progression to invasive disease. J. Am. Acad. Dermatol. 42, 23-24, 2000.
12. Gown A.M., and Vogel A.M.: Monoclonal antibodies to intermediate filament proteins of human cells: unique and crossreacting antibodies. J. Cell Biol. 95, 414-424, 1982.
13. Gown A.M., and Vogel A.M.: Monoclonal antibodies to human intermediate filament proteins. II. Distribution of filament proteins in normal human tissues. Am. J. Pathol. 114, 309-321, 1984.
14. Gown A.M., and Vogel A.M.: Monoclonal antibodies to human intermediate filament proteins. III. Analysis of tumors. Am. J. Clin. Pathol. 84, 413-424, 1985.
15. Graham J.H., and Helwig E.B.: Erythroplasia of Queyrat. A clinicopathologic and histochemical study. Cancer 32, 1396-1414, 1973.
16. Grussendorf-Conen E.I., and Giesen M.: Papillomavirus common antigen in Bowen's disease. Dermatologica 181, 11-15, 1990.
17. Hashimoto K., and Mehregan A.H.: Tumors of the epidermis, Butterworth, Stoneham, 1990.
18. Hatchoh M., Ueda K., Imamura Y., Noriki S., and Fukuda M.: Qualitative and quantitative changes in nuclear DNA and phenotypic gene expression in human malignant skin tumors during their progression. Eur. J. Histochem. 36, 289-302, 1992.
19. Hsu C.H., Yang S.A., Wang J.Y., Yu H.S., and Lin S.R.: Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan. Br. J. Cancer 80, 1080-1086, 1999.
20. Ikenberg H., Gissmann L., Gross G., Grussendorf-Conen E.I., and zur Hausen H.: Human papillomavirus type-16-related DNA in genital Bowen's disease and in Bowenoid papulosis. Int. J. Cancer 32, 563-565, 1983.
21. Kanitakis J., Hoyo E., Hermier C., Chouvet B., and Thivolet J.: Nucleolar organizer region enumeration in keratoacanthomas and squamous cell carcinomas of the skin. Cancer 69, 2937-2941, 1992.
22. Kettler A.H., Rutledge M., Tschen J.A., and Buffone G.: Detection of human papillomavirus in nongenital Bowen's disease by in situ DNA hybridisation. Arch. Dermatol. 126, 777-781, 1990.
23. Kirkham N.: Tumors and cysts of the epidermis In: Lever' s histopathology of the skin, 8th edn. (Eds. Elder D.. Elenitsas R., Jaworsky C., and Johnson B.), Lippincott-Raven, Philadelphia, pp. 685-746, 1997.
24. Kossard S., and Rosen R.: Cutaneous Bowen's disease. An analysis of 1001 cases according to age, sex, and site. J. Am. Acad. Dermatol. 27, 406-410, 1992.
25. Kuo T.T., Hu S., Lo S.K., and Chan H.L.: p53 expression and proliferative activity in Bowen's disease with or without chronic arsenic exposure. Hum. Pathol. 28, 786-790, 1997.
26. Lee M.M., and Wick M.M.: Bowen's disease. C.A. Cancer J. Clin. 40, 237-242, 1990.
27. Li J., and Lee Y.S.: Proliferating cell nuclear antigen (PCNA) expression in pseudoepitheliomatous hyperplasia, keratoacanthoma and squamous cell carcinoma of the skin. Ann. Acad. Med. Singapore 25, 526-530, 1996.
28. Mackie R.M., White S.I., Seywright M.M., and Young H.: An assessment of the value of Ag NOR staining in the identification of dysplastic and other borderline melanocytic naevi. Br. J. Dermatol. 120, 511-516, 1989.
29. Mackie R.M.: Epidermal skin tumours. In: Rook/Wilkinson/Ebling textbook of dermatology, 6th edn. (Eds. Champion R.H., Burton J.L., Burns D.A., and Breathnach S.M.) Blackwell Science, Oxford, pp. 1651-1693, 1998.
30. Matsuta M., Matsuta M., Kon S., Thompson C., LeBoit P.E., Weier H.U., and Gray J.W.: Interphase cytogenetics of melanocytic neoplasms: numerical aberrations of chromosomes can be detected in interphase nuclei using centromeric DNA probes. J. Cutan. Pathol. 21, 1-6, 1994.
31. McGregor J.M., Yu C.C., Dublin E.A., Levison D.A., and MacDonald D.M.: Aberrant expression of p53 tumour-suppressor protein in non-melanoma skin cancer. Br. J. Dermatol. 127, 463-469, 1992.
32. Miki Y., Kawatsu T., Matsuda K., Machino H., and Kubo K.: Cutaneous and pulmonary cancers associated with Bowen's disease. J. Am. Acad. Dermatol. 6, 26-31, 1982.
33. Newton J.A., Camplejohn R.S., and McGibbon D.H.: A flow cytometric study of the significance of DNA aneuploidy in cutaneous lesions. Br. J. Dermatol. 117, 169-174, 1987.
34. Onodera H., Nakamura S., and Sugai T.: Cell proliferation and p53 protein expressions in cutaneous epithelial neoplasms. Am. J. Dermatopathol. 18, 580-588, 1996.
35. Pinkus H.: Keratosis senilis: a biologic concept of its pathogenesis and diagnosis based on the study of normal epidermis and 1730 seborrheic and senile keratoses. Am. J. Clin. Pathol. 29, 193-207, 1958.
36. Reizner G.T., Chuang T.Y., Elpern D.J., Stone J.L., and Farmer E.R.: Bowen's disease (squamous cell carcinoma in situ) in Kauai, Hawaii. A population-based incidence report. J. Am. Acad. Dermatol. 31, 596-600, 1994.
37. Ro Y.S., Cooper P.N., Lee J.A., Quinn A.G., Harrison D., Lane D., Home C.H., Rees J.L.. and Angus B.: p53 protein expression in benign and malignant skin tumours. Br. J. Dermatol. 128, 237-241, 1993.
38. Seiji M., and Mizuno R: Electron microscopic study of Bowen's disease. Arch. Dermatol. 99, 3-16, 1969.
39. Sober A.J., and Burstein J.M.: Precursors to skin cancer. Cancer 75, 645-650, 1995.
40. Suzuki T., Ueda M., Ogata K., Horikoshi T., Munakata N., and Ichihashi M.: Doses of solar ultraviolet radiation correlate with skin cancer rates in Japan. Kobe J. Med. Sci. 42, 375-388, 1996.
41. Tada H., Hatoko M., Tanaka A., Kuwahara M., and Muramatsu T.: Expression of desmoglein I and plakoglobin in skin carcinomas. J. Cutan. Pathol. 27, 24-29, 2000.
42. Takata M., and Matsui Y.: Proliferating cell nuclear antigen (PCNA) and p53 protein expression in Bowen's disease. J. Dermatol. 21, 947-952, 1994.
43. Thestrup-Pedersen K., Ravnborg L., and Reymann F.: Morbus Bowen. A description of the disease in 617 patients. Acta. Derm. Venereol. 68. 236-239, 1988.
44. Tsuji T., Shrestha P., Yamada K., Takagi H., Shinozaki F., Sasaki K., Maeda K., and Mori M.: Proliferating cell nuclear antigen in malignant and pre-malignant lesions of epithelial origin in the oral cavity and the skin: an immunohistochemical study. Virchows Arch. A. Pathol. Anat. Histopathol. 420. 377-383, 1992.
45. Yeh S., How S.W., and Lin C.S.: Arsenical cancer of skin. Histologic study with special reference to Bowen's disease. Cancer 21, 312-339, 1968.
46. Yu C.C., Fletcher C.D., Newman P.L., Goodlad J.R., Burton J.C., and Levison D.A.: A comparison of proliferating cell nuclear antigen (PCNA) immunostuining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours. J. Pathol. 166, 147-152, 1992.
47. Ziegler A., Jonason A.S., Leffell D.J., Simon J.A., Sharma H.W., Kimmelman J., Remington L., Jacks T., and Brash D.E.: Sunburn and p53 in the onset of skin cancer. Nature 372, 773-776, 1994.